Common “First in Man” approaches vs. The Lost Art of Formulation Development
In today’s market, pharmaceutical and biotech companies are being asked to do more…with less. Diminishing resources, pipelines, competition, and increased regulatory hurdles are forcing us to rethink our strategy. We must work smarter, not harder.
According to Pharmaceutical Technology, there has been a surge in the number of combination product (i.e. where a drug product is combined with a medical device) launches in recent years and this trend is set to continue as more companies seek to extend the life of existing branded medicines.